These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12096503)

  • 1. [A case of pulmonary infiltration with eosinophilia (PIE) syndrome induced by bucillamine treatment of rheumatoid arthritis].
    Kishimoto N; Fujii K
    Nihon Kokyuki Gakkai Zasshi; 2002 Apr; 40(4):321-5. PubMed ID: 12096503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of bucillamine-induced interstitial pneumonia].
    Hara A; Sakamoto O; Matsumoto M; Sakata T; Kohrogi H; Sugimoto M; Ando M; Araki S; Iwakiri T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Sep; 30(9):1743-8. PubMed ID: 1447852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of drug-induced interstitial pneumonitis in rheumatoid arthritis treated with bucillamine].
    Matsushima H; Takayanagi N; Sakamoto T; Motegi M; Ubukata M; Yanagisawa T; Sugita Y; Kanazawa M; Kawabata Y
    Nihon Kokyuki Gakkai Zasshi; 2001 Jan; 39(1):55-9. PubMed ID: 11296388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of bucillamine-induced pneumonitis].
    Tanaka H; Nakahara K; Goto K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Apr; 30(4):695-701. PubMed ID: 1405091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of rheumatoid arthritis developing pemphigus-like skin lesion during treatment with bucillamine].
    Amasaki Y; Sagawa A; Atsumi T; Jodo S; Nakabayashi T; Watanabe I; Mukai M; Fujisaku A; Nakagawa S; Kobayashi H
    Ryumachi; 1991 Oct; 31(5):528-34; discussion 531-3. PubMed ID: 1837388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of rheumatoid arthritis complicated with a pneumonitis during concomitant treatment with methotrexate and bucillamine].
    Miwa Y; Kaga S; Hanaoka R; Shiozawa F; Hanyuda M; Kasama T; Negishi M; Ide H
    Ryumachi; 2002 Feb; 42(1):70-5. PubMed ID: 11925909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of bucillamine-induced interstitial pneumonia with positive lymphocyte stimulation test for bucillamine using bronchoalveolar lavage lymphocytes.
    Saito Y; Nei T; Abe S; Usuki J; Azuma A; Nakayama T; Fukuda Y; Kudoh S
    Intern Med; 2007; 46(20):1739-43. PubMed ID: 17938531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bucillamine-associated membranous nephropathy in a patient with rheumatoid arthritis].
    Kawano M; Nomura H; Iwainaka Y; Nakashima A; Koni I; Tofuku Y; Takeda R
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):817-21. PubMed ID: 2273598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of rheumatoid arthritis associated with agranulocytosis during bucillamine treatment].
    Negishi M; Yamazaki J; Hosaka M; Iwabuchi H; Matsuda A; Kanemitsu H; Hiramatsu K; Kaga S; Hashimoto M; Kasama T
    Ryumachi; 1994 Jun; 34(3):651-5. PubMed ID: 8052932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lung injury associated with bucillamine therapy].
    Negishi M; Kaga S; Kasama T; Hashimoto M; Fukushima T; Yamagata N; Tabata M; Kobayashi K; Ide H; Takahashi T
    Ryumachi; 1992 Apr; 32(2):135-9. PubMed ID: 1595005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopharmacological evaluation of bucillamine in rheumatoid arthritis.
    Matsuno H; Kitano T; Matsushita I; Tsuji H; Ochiai H
    Drugs Exp Clin Res; 1993; 19(5):205-11. PubMed ID: 8174492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bucillamine-induced Pneumonitis in a Patient with Rheumatoid Arthritis-associated Interstitial Pneumonia: A Case Report and Review of the Literature.
    Fukada A; Toyoshima M; Nozue T; Suda T
    Intern Med; 2019 Aug; 58(15):2207-2211. PubMed ID: 30918198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bucillamine-induced dermatomyositis-like clinical features in a patient with rheumatoid arthritis].
    Takeda T; Shimizu Y; Takeuchi M; Hashimoto S; Nagai C; Uchiyama S; Iwata M
    Rinsho Shinkeigaku; 2005 Jan; 45(1):45-8. PubMed ID: 15715001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of eosinophilic pneumonia due to tolfenamic acid].
    Nakatsumi Y; Nomura M; Yasui M; Fujimura M; Matsuda T; Kitagawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Oct; 31(10):1322-6. PubMed ID: 8271669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bucillamine-induced pemphigus vulgaris.
    Yanagishita T; Tamada Y; Watanabe D
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1242-3. PubMed ID: 24641261
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of progressive systemic sclerosis with Sjögren's syndrome complicated by nephrotic syndrome caused by bucillamine].
    Ogawa N; Itoh M; Sudo Y; Endo S; Ohashi H; Okugawa T; Furuya R; Hishida A
    Ryumachi; 1990 Oct; 30(5):362-6, 308; discussion 366-8. PubMed ID: 2084858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of BOOP developed during bucillamine treatment for rheumatoid.
    Lee YH; Kim YR; Ji JD; Shim JJ; Kang KH; Lee JH; Kim HK; Song GG
    Korean J Intern Med; 2001 Mar; 16(1):36-9. PubMed ID: 11417303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bucillamine-induced toxic epidermal necrolysis and fixed drug eruption.
    Izumi A; Katsumi S; Kobayashi N; Niizeki H; Asada H; Miyagawa S
    J Dermatol; 2005 May; 32(5):397-401. PubMed ID: 16043905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of rheumatoid arthritis with bucillamine-induced myasthenia gravis treated by immunoadsorption therapy].
    Sawa N; Ubara Y; Hara S; Hideyuki K; Tagami T; Yokoyama K; Takemoto F; Yamada A; Mori T; Mikami A; Tachibana S; Nakase K
    Ryumachi; 1999 Feb; 39(1):33-8. PubMed ID: 10332215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcorneal pustular dermatosis-type IgA pemphigus induced by thiol drugs.
    Kishimoto K; Iwatsuki K; Akiba H; Motoki Y; Kaneko F
    Eur J Dermatol; 2001; 11(1):41-4. PubMed ID: 11174137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.